Filtros de búsqueda

Lista de obras de

19p13.1 is a triple-negative-specific breast cancer susceptibility locus

artículo científico publicado en 2012

5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group

artículo científico publicado en 1997

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

article

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer

artículo científico publicado en 2011

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

artículo científico publicado en 2010

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

artículo científico publicado en 2006

A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon

scientific article published on 27 January 2014

A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas

artículo científico publicado en 2013

A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer

artículo científico publicado en 2005

A phase II study of paclitaxel in advanced breast cancer resistant to anthracyclines

scientific article published on 01 January 1996

A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group study

artículo científico publicado en 1997

A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

artículo científico publicado en 2009

A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinoma

artículo científico publicado en 2003

A phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study.

artículo científico publicado en 1993

A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16)

A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group

artículo científico publicado en 1996

A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study

artículo científico publicado en 2008

A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study.

artículo científico publicado en 2000

A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study

artículo científico publicado en 2008

A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer

artículo científico publicado en 2010

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study

artículo científico publicado en 2011

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)

artículo científico publicado en 2014

A twisted kiss: in vitro and in vivo evidence of genetic variation and suppressed transcription of the metastasis-suppressor gene KiSS1 in early breast cancer

artículo científico publicado en 2010

Accelerated Bifractionated Radiation with Concurrent Cisplatin Administration in Locally Advanced Head and Neck Cancer: A Feasibility Study ⬇️

artículo científico publicado el 1 de julio de 1997

Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group

artículo científico publicado en 2004

Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study

artículo científico publicado en 2004

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF and weekly paclitaxel in patients with resected high-risk breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study

artículo científico publicado en 2008

Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG).

artículo científico publicado en 2008

Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience

artículo científico publicado en 2006

Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.

artículo científico publicado en 2005

Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region

artículo científico publicado en 2006

An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

artículo científico publicado en 2001

Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1.

artículo científico publicado en 2009

Angiogenesis and apoptosis-related protein (p53, bcl-2, and bax) expression versus response of gastric adenocarcinomas to paclitaxel and carboplatin chemotherapy.

artículo científico publicado en 2001

Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer.

artículo científico publicado en 1999

Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.

artículo científico publicado en 2000

Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer

artículo científico publicado en 2014

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

artículo científico publicado en 2016

Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2017

BRCA1 mutation analysis in breast/ovarian cancer families from Greece

artículo científico publicado en 2000

Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse

artículo científico publicado en 2001

Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study.

artículo científico publicado en 1998

Bevacizumab in the treatment of breast cancer

artículo científico publicado en 2009

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

artículo científico publicado en 2013

Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I study

artículo científico publicado en 2004

Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature

artículo científico publicado en 2005

Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas

article

Burkitt's lymphoma in Greek adults

Burkitt's lymphoma in Greek adults. A study of the Hellenic co-operative oncology group

CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2007

CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases

artículo científico publicado en 2015

CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results

artículo científico publicado en 2007

Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group study

scientific article published on 01 March 1996

Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

Carboplatin and oral etoposide in the treatment of patients with advanced breast cancer refractory to anthracyclines.

artículo científico publicado en 1993

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer

artículo científico publicado en 2008

Carboplatin and paclitaxel in metastatic or recurrent cervical cancer

artículo científico publicado en 2009

Carboplatin, continuous infusion fluorouracil and mid-cycle high-dose methotrexate as initial treatment in patients with locally advanced head and neck cancer. Hellenic Co-operative Oncology Group Study.

artículo científico publicado en 1991

Cardiotoxicity evaluation in patients treated with a mitoxantrone combination as adjuvant chemotherapy for breast cancer

artículo científico publicado en 1992

Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical features

artículo científico publicado en 2004

Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients.

artículo científico publicado en 2018

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

artículo científico

Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?

artículo científico publicado en 2005

Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study

scientific article published on 01 January 1997

Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group study

artículo científico publicado en 1996

Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.

artículo científico publicado en 1994

Clinical and molecular prognostic factors in operable laryngeal cancer.

artículo científico publicado en 2005

Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group

artículo científico publicado en 2007

Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group

artículo científico publicado en 2005

Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer

artículo científico publicado en 1999

Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.

artículo científico publicado en 2007

Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group

artículo científico publicado en 2000

Combination chemotherapy with prednimustine, adriamycin, vincristine (VAP) in advanced breast cancer. A phase II study

scientific article published on 01 December 1987

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer ⬇️

artículo científico publicado el 24 de agosto de 2010

Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2004

Combined therapy of locally advanced squamous epithelial cancers in the area of the head and neck

artículo científico publicado en 1988

Common breast cancer susceptibility loci are associated with triple-negative breast cancer

artículo científico publicado en 2011

Comparison of filgrastim and pegfilgrastim to prevent neutropenia and maintain dose intensity of adjuvant chemotherapy in patients with breast cancer.

artículo científico publicado en 2014

Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study

artículo científico publicado en 2016

Concurrent radiation and intracarotid cisplatin infusion in malignant gliomas: a feasibility study

artículo científico publicado en 1997

Continuation of trastuzumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of 80 cases by the hellenic cooperative oncology group

artículo científico publicado en 2003

Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases

scientific article published on 02 June 2009

Correlation of proliferating cell nuclear antigen assessment, histologic parameters and age with survival in patients with glioblastoma multiforme.

artículo científico publicado en 1995

Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.

artículo científico publicado en 2013

Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study

artículo científico publicado en 1996

DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome

artículo científico publicado en 2012

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

artículo científico publicado en 2005

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration

artículo científico publicado en 2013

Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes

artículo científico publicado en 2014

Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel

artículo científico publicado en 2012

Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study

artículo científico publicado en 1998

Disease evolution and heterogeneity in bilateral breast cancer

artículo científico publicado en 2016

Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 1999

Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2003

Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study

artículo científico publicado en 2000

Docetaxel in combination with dacarbazine in patients with advanced melanoma

artículo científico publicado en 2002

Does substitution of surgery with induction chemotherapy preserve organ function in inoperable head and neck cancer? A retrospective analysis of 73 cases

artículo científico publicado en 1994

Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study

artículo científico publicado en 2013

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

artículo científico publicado en 2014

Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer.

artículo científico publicado en 2001

Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer.

artículo científico publicado en 2001

Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group

artículo científico publicado en 2001

Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer

artículo científico publicado en 2009

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial

artículo científico publicado en 2014

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.

artículo científico publicado en 2014

Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial

artículo científico publicado en 2008

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

artículo científico publicado en 2010

Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients

artículo científico publicado en 1999

Elderly patients with squamous lung carcinoma: faring better or worse?

artículo científico publicado en 2006

Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).

artículo científico publicado en 2009

Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience

artículo científico publicado en 2007

Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin

artículo científico publicado en 2015

Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma

artículo científico publicado en 2015

Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays

artículo científico publicado en 2013

Evaluation of dHPLC in mutation screening of the APC gene in a Greek FAP cohort.

artículo científico publicado en 2003

Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab

scientific article published on 01 November 2018

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

artículo científico publicado en 2008

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Co

artículo científico publicado en 2013

Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy

artículo científico publicado en 2006

Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNA

artículo científico publicado en 2015

Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer

artículo científico publicado en 2016

Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study

artículo científico publicado en 2011

Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients

artículo científico publicado en 2013

Extragonadal choriocarcinoma in a patient with Down syndrome.

artículo científico publicado en 1994

Factors influencing complete response and survival in patients with head and neck cancer treated with platinum-based induction chemotherapy. A Hellenic Co-operative Oncology Group Study ⬇️

artículo científico publicado el 1 de julio de 1992

Favorable Outcome of Ovarian Germ Cell Malignancies Treated with Cisplatin or Carboplatin-Based Chemotherapy: A Hellenic Cooperative Oncology Group Study

Fifteen-year trends in metastatic breast cancer survival in Greece

artículo científico publicado en 2010

First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study

artículo científico publicado en 2001

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group

artículo científico publicado en 1998

Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group

artículo científico publicado en 2000

Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group

artículo científico publicado en 1996

Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study

artículo científico publicado en 2004

G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting

artículo científico publicado en 2001

G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history

article published in 2007

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group

artículo científico publicado en 2000

Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation

artículo científico publicado en 2008

Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study

artículo científico publicado en 2005

Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group.

artículo científico publicado en 2007

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

artículo científico publicado en 2008

Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

artículo científico publicado en 2016

Genetic alterations of the APC gene in familial adenomatous polyposis patients of the hellenic group for the study of colorectal cancer.

artículo científico publicado en 2003

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

artículo científico publicado en 2014

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer

artículo científico publicado en 2013

Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers

artículo científico publicado en 2018

Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed

artículo científico publicado en 2002

Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors

artículo científico publicado en 2012

Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients

HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study

artículo científico publicado en 2016

HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients

artículo científico publicado en 2013

HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma

artículo científico publicado en 2008

Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation

artículo científico publicado en 2016

Haplotypes of human leukocyte antigens among patients with nasopharyngeal cancer in Greece

artículo científico publicado en 1997

High prevalence of BRCA1 founder mutations in Greek breast/ovarian families.

artículo científico publicado en 2013

High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group study

artículo científico publicado en 1995

High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group study

artículo científico publicado en 1991

High-dose leucovorin, fluorouracil and oral dipyridamole in the treatment of advanced colorectal cancer

artículo científico publicado en 1991

Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer

artículo científico publicado en 2010

Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer

artículo científico publicado en 2013

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

artículo científico publicado en 2017

Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised tri

artículo científico publicado en 2015

Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study

artículo científico publicado en 2015

Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression

artículo científico publicado en 2012

In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients

artículo científico publicado en 2014

Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region

artículo científico publicado en 1990

Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study

artículo científico publicado en 2005

Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck

artículo científico publicado en 1989

Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck.

artículo científico publicado en 2009

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer

artículo científico publicado en 2014

Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer

artículo científico publicado en 2013

Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC).

artículo científico publicado en 2015

Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic study

artículo científico publicado en 2004

Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG).

artículo científico publicado en 1997

Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer ⬇️

artículo científico publicado el 1 de enero de 1994

Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study

artículo científico publicado en 2007

Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer

artículo científico publicado en 2016

Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases.

artículo científico publicado en 2012

Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation

artículo científico publicado en 2007

Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trials

artículo científico publicado en 2015

Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy

scientific article published on 01 December 1999

Irinotecan and oxaliplatin combination, as second-line treatment, in fluoropyrimidine-pretreated advanced colorectal cancer. A phase II study by the Hellenic Cooperative Oncology Group (HeCOG).

artículo científico publicado en 2005

Irinotecan and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. A phase II study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2002

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study

artículo científico publicado en 2005

Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer

artículo científico publicado el 1 de octubre de 2010

Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial

artículo científico publicado en 2013

Kit expression in male germ cell tumors.

artículo científico

Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.

artículo científico publicado en 2014

Laryngeal preservation in cases of advanced laryngeal cancer treated with platinum based induction chemotherapy befire local treatment ⬇️

artículo científico publicado el 1 de noviembre de 1991

Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anem

artículo científico publicado en 2015

Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature

artículo científico publicado en 2008

Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: a Hellenic Co-operative oncology Group study

artículo científico publicado en 1997

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)

article

MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

artículo científico publicado en 2009

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2016

Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).

artículo científico publicado en 2014

Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer

artículo científico publicado en 2015

Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) study

artículo científico publicado en 1993

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women

artículo científico publicado en 2005

Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer

artículo científico publicado en 2006

Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer

artículo científico publicado en 2007

Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer

artículo científico publicado en 2012

Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype

artículo científico publicado en 2013

Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study

artículo científico publicado en 2007

Multidisciplinary approach to the treatment of locally and regionally advanced non-small cell lung cancer: University of Miami experience

artículo científico publicado en 1993

Multimodality treatment of non-small cell lung cancer: response to cisplatin, VP-16, and 5-FU chemotherapy and to surgery and radiation therapy

artículo científico publicado en 1988

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

Mutational profiling of the RAS, PI3K, MET and b-catenin pathways in cancer of unknown primary: a retrospective study of the Hellenic Cooperative Oncology Group.

artículo científico publicado en 2014

Mutational spectrum of APC and genotype-phenotype correlations in Greek FAP patients

artículo científico publicado en 2010

Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation.

artículo científico publicado en 1998

Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group

artículo científico publicado en 2002

Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients.

artículo científico publicado en 2009

Non-Hodgkin’s Lymphomas in Greece according to the WHO Classification of Lymphoid Neoplasms

Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data

artículo científico publicado en 2006

Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.

artículo científico publicado en 2006

Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary

artículo científico publicado en 2013

Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis

artículo científico publicado en 2010

Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients

artículo científico publicado en 2005

Opposite Prognostic Impact of Single PTEN-loss and Mutations in Early High-risk Breast Cancer

artículo científico publicado en 2019

Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin

artículo científico publicado en 1995

Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study

artículo científico publicado el 1 de agosto de 1997

Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group

artículo científico publicado en 2005

Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2010

Paclitaxel and carboplatin in inoperable non-small cell lung cancer

artículo científico publicado en 1996

Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: A phase II study ⬇️

artículo científico publicado el 1 de julio de 1997

Paclitaxel and carboplatin in nonoperable non-small cell lung cancer.

artículo científico publicado en 1996

Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study

artículo científico publicado en 1997

Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group

artículo científico publicado en 2004

Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group

artículo científico publicado en 1999

Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2007

Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)

scientific article published on 29 September 2010

Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).

artículo científico publicado en 2004

Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group

artículo científico publicado en 1997

Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group

artículo científico publicado en 1997

Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer.

artículo científico publicado en 1997

Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial

artículo científico publicado en 2002

Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study

Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study

artículo científico publicado el 1 de octubre de 1997

Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study

artículo científico publicado en 2005

Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: accumulating evidence for synergy, efficacy, and safety

artículo científico publicado en 2006

Paclitaxel: epirubicin in metastatic breast cancer--a review

artículo científico publicado en 2001

Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors

artículo científico publicado en 2008

Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hell

artículo científico publicado en 2009

Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).

artículo científico publicado en 2004

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

artículo científico publicado en 2006

Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer

artículo científico publicado en 2005

Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study

artículo científico publicado en 2010

Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group Study

artículo científico publicado en 1996

Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer

artículo científico publicado en 2003

Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma

artículo científico publicado en 2008

Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment

artículo científico publicado en 2009

Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study

artículo científico publicado en 2000

Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer

artículo científico publicado en 2013

Phase III, randomized, double-blind, multicenter trial comparing orteronel (TAK-700) plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer that has progressed during or after docetaxel-based th

artículo científico publicado en 2015

Platinum-Based Chemotherapy Followed by Radiation Therapy of Locally Advanced Nasopharyngeal Cancer a Retrospective Analysis of 39 Cases ⬇️

artículo científico publicado el 1 de enero de 1991

Platinum-based induction chemotherapy followed by radiation as definitive treatment for patients with locally advanced cancer of the oral cavity, oropharynx and hypopharynx. A retrospective analysis of 32 cases

artículo científico publicado en 1991

Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation.

artículo científico publicado en 2006

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group

artículo científico publicado en 2005

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.

artículo científico publicado en 2007

Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study

artículo científico publicado en 2008

Predictive biomarkers to chemotherapy in patients with advanced melanoma receiving the combination of cisplatin--vinblastine--temozolomide (PVT) as first-line treatment: a study of the Hellenic Cooperative Oncology Group (HECOG).

artículo científico publicado en 2015

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.

artículo científico publicado en 2012

Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases

artículo científico publicado en 2013

Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group.

artículo científico publicado en 2003

Primary angiosarcoma of the brain: case report

artículo científico publicado en 1996

Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group).

artículo científico publicado en 1998

Primary extranodal non-Hodgkin's lymphoma of the head and neck

artículo científico publicado el 1 de enero de 1992

Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG).

artículo científico publicado en 2006

Primary mediastinal large B-cell lymphoma: clinical study of a distinct clinical entity and treatment outcome in 20 patients: review of the literature

artículo científico publicado en 2004

Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2002

Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary.

artículo científico publicado en 2012

Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers

artículo científico publicado en 2017

Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab

Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial

artículo científico publicado en 2015

Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer

artículo científico publicado en 2017

Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer

artículo científico

Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer

artículo científico publicado en 2014

Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal carcinoma

artículo científico publicado en 2006

Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.

artículo científico publicado en 2002

Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapy: a pooled analysis of two randomized studies

artículo científico publicado en 2005

Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.

artículo científico publicado en 2018

Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial

artículo científico publicado en 2004

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer.

artículo científico publicado en 2019

Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG)

artículo científico publicado en 2013

Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer.

artículo científico publicado en 2007

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.

artículo científico publicado en 2012

Prognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primary

artículo científico publicado en 2015

Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer

artículo científico publicado en 2014

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer

article published in 2018

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

artículo científico publicado en 2010

Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.

artículo científico publicado en 2011

Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy

artículo científico publicado en 1996

Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution.

artículo científico publicado en 1996

Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.

artículo científico publicado en 2014

Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary site

artículo científico publicado en 2013

Radiation and concomitant weekly administration of paclitaxel in patients with glioblastoma multiforme. A phase II study.

artículo científico publicado en 1999

Radiation and concurrent carboplatin administration in locally advanced head and neck cancer. A Hellenic Cooperative Oncology Group Study.

artículo científico publicado en 1995

Radiation therapy and concurrent cisplatin administration in locally advanced head and neck cancer. A Hellenic Co-operative Oncology Group study

artículo científico publicado en 1994

Randomised trial of epirubicin versus fluorouracil in advanced gastric cancer. An International Collaborative Cancer Group (ICCG) study

artículo científico publicado en 1994

Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

artículo científico publicado en 2001

Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study

scientific article published on 01 September 1994

Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.

artículo científico publicado en 2009

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.

artículo científico publicado en 2005

Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients

artículo científico publicado en 2005

Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanoma

scientific article published on 01 June 1996

Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.

artículo científico publicado en 2007

Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome

artículo científico publicado en 2018

Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma

artículo científico publicado en 2003

Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma. A pilot study

artículo científico publicado en 2003

STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN ⬇️

artículo científico publicado el 1 de febrero de 2011

Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research

artículo científico publicado en 2012

Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study

artículo científico publicado en 2010

Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families

artículo científico publicado en 2010

Second line chemotherapy with 5 fluorouracil and vinorelbine in anthracycline and taxane pretreated patients with metastatic breast cancer

artículo científico publicado en 2004

Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study

artículo científico publicado en 2004

Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: a Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study

artículo científico publicado en 2000

Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group.

artículo científico publicado en 2017

Sensitivity of cultured human pancreatic carcinoma cells to dihydroxyanthracenedione

artículo científico publicado en 1984

Sensitivity of human pancreatic carcinoma cell line (MIA PaCa-2) to Bisantrene and Theprubicin in vitro

artículo científico publicado en 1984

Serum soluble interleukin-2 receptors in epithelial ovarian cancer patients

artículo científico publicado en 1995

Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study

artículo científico publicado en 2015

Soluble interleukin-2 receptors in patients with advanced colorectal carcinoma.

artículo científico publicado en 1996

Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).

artículo científico publicado en 1999

Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study ⬇️

artículo científico publicado el 1 de septiembre de 1992

Sunitinib treatment in patients with severe renal function impairment: a report of four cases by the Hellenic Cooperative Oncology Group.

artículo científico publicado en 2009

Supraglottic laryngectomy: experience with 66 patients over 20 years

artículo científico publicado en 1993

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis

artículo científico publicado en 2016

Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study

artículo científico publicado en 2012

Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival.

artículo científico publicado en 2006

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting

artículo científico publicado en 2016

Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics

artículo científico publicado en 2009

Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefit

artículo científico publicado en 2007

Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2005

Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2006

Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2002

The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases

artículo científico publicado en 2017

The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping

artículo científico publicado en 2014

The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic property

scientific article published on 01 September 1996

The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study

artículo científico publicado en 2018

The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2006

The fate of BRCA1-related germline mutations in triple-negative breast tumors

scientific article published on January 2017

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer

artículo científico publicado en 2016

The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models

artículo científico publicado en 2009

The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study

artículo científico publicado en 2004

The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Onco

artículo científico publicado en 2012

The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab

artículo científico publicado en 2013

The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival

artículo científico publicado en 2013

The role of taxanes as a component of neoadjuvant chemotherapy for breast cancer ⬇️

artículo científico publicado el 1 de mayo de 2003

The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study

scientific article published on 01 December 1994

Toxicity of FED chemotherapy in non-small-cell lung cancer.

artículo científico publicado en 1987

Transcriptional activity of human epidermal growth factor receptor family and angiogenesis effectors in locoregionally recurrent head and neck squamous cell carcinoma and correlation with patient outcome

artículo científico publicado en 2009

Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2008

Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities

Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study

artículo científico publicado en 2003

Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.

artículo científico publicado en 2002

Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program

artículo científico publicado en 2005

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III tri

artículo científico publicado en 2011

Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes

artículo científico publicado en 2016

Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.

artículo científico publicado en 2018

Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer.

artículo científico publicado en 2002

Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials

artículo científico publicado en 2015

Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial

artículo científico publicado en 2003

Usefulness of Tumor Volumetry as a Prognostic Factor of Survival in Head and Neck Cancer ⬇️

artículo científico publicado el 1 de mayo de 2003

Vertical partial laryngectomy: our results after treating 81 cases of T2and T3laryngeal carcinomas ⬇️

artículo científico publicado el 1 de abril de 1992

Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology Group

artículo científico publicado en 2004

Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2.

artículo científico publicado en 2012

Volumetric and MGMT parameters in glioblastoma patients: survival analysis

artículo científico publicado en 2012

Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.

artículo científico publicado en 1999

Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group

artículo científico publicado en 2009

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

artículo científico publicado en 2012

c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival

artículo científico publicado en 2000

hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients

artículo científico publicado en 2005

p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumab.

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda